Main Catalog

Found 84
Sort By
AMCP 2021 Virtual
Member
Non-Member

Drug Pipeline: Traditional Pharmaceuticals and Biosimilars

This session is a recording from AMCP 2021 Virtual.
Drug Pipeline
AMCP 2021 Virtual
Member Free
Non-Member Free

Emerging Patterns in the Adoption of New-to-Market Oncology Biosimilars

This session is a recording from AMCP 2021 Virtual.
Biosimilars
AMCP 2021 Virtual
Member
Non-Member

New Developments in Alzheimer's Treatment

This session is a recording from AMCP 2021 Virtual.
Alzheimer's
AMCP 2021 Virtual
Member
Non-Member

The First 100 Days and Beyond: A Discussion on Health Care Policy with Chris Jennings

This session is a recording from AMCP 2021 Virtual. It is not accredited for continuing pharmacy education credit.
Health Policy
AMCP 2021 Virtual
Member
Non-Member

Medicare Part D: Past, Present and Future

This session is a recording from AMCP 2021 Virtual. It is not accredited for continuing pharmacy education (CPE) credit.
Medicare and Medicaid
AMCP 2021 Virtual
Member
Non-Member

2021 Federal and State Legislative and Regulatory Update

This session is a recording from AMCP 2021 Virtual.
Legislation
AMCP 2021 Virtual
Member
Non-Member

Specialty Pipeline and Forecasts 2021

This session is a recording from AMCP 2021 Virtual.
Drug Pipeline Specialty
AMCP 2021 Virtual
Member
Non-Member

Medicare Part D Bids: How Do Actuaries Get to the Answers?

This session is a recording from AMCP 2021 Virtual.
Medicare and Medicaid
Webcasts
Member Free
Non-Member Free

Innovations in Oncology: Focus on Renal Cell Carcinoma

During this CPE session, presenters will discuss new data, recent changes to treatment guidelines, and explore emerging innovations that may impact Renal Cell Carcinoma management in the future
Oncology
Webcasts
Member Free
Non-Member Free

Innovations in Oncology- Focus on Prostate Cancer

During this CPE session, presenters will discuss new data, recent changes to treatment guidelines, and explore emerging innovations that may impact Prostate Cancer management in the future
Oncology